Check out your Company Bowl for anonymous work chats.
Construction started in Freiburg! The symbolic groundbreaking today marked the start of a significant expansion of the existing production and R&D activities in Freiburg. In the Southwest of Germany, Sartorius is building a new center of excellence for developing and producing quality-critical materials for the cell and gene therapy market. With a gross floor area of almost 10,000 square meters, the new building will include production rooms, laboratories, and further space for technology and offices. The facility will be operated in a CO2-neutral manner, among other things, through the use of geothermal energy for heating, cold well water for cooling, photovoltaic power generation and a green facade. Read the press release for further details: srtrs.info/cellgenix-construction-en
MSCI, one of the world's leading providers of ESG ratings, upgraded Sartorius from A to AA in its recent analysis. This year, only 10% of companies received a higher rating. The scorecard consists of three categories: environmental, social and governance. Sartorius scored particularly well for "strong management practices to address carbon emissions relative to peers, including targets to reduce carbon emissions", "fewer apparent product recalls compared to peers", "governance practices that appear generally well aligned with investor interests", and "evidence of detailed policies on business ethics and corruption". Especially in the governance category MSCI rated Sartorius well above the industry average. Learn more about sustainability at Sartorius: www.sartorius.com/sustainability
MSCI, one of the world's leading providers of ESG ratings, upgraded Sartorius from A to AA in its recent analysis. This year, only 10% of companies received a higher rating. The scorecard consists of three categories: environmental, social and governance. Sartorius scored particularly well for "strong management practices to address carbon emissions relative to peers, including targets to reduce carbon emissions", "fewer apparent product recalls compared to peers", "governance practices that appear generally well aligned with investor interests", and "evidence of detailed policies on business ethics and corruption". Especially in the governance category MSCI rated Sartorius well above the industry average. Learn more about sustainability at Sartorius: www.sartorius.com/sustainability
How much startup is in your research? Around thirty PhD students and postdocs were invited to think about this question at a "phd-to-innovator" workshop at the Sartorius Campus in Göttingen. The two-day workshop, organized by Sartorius' partner Young Entrepreneurs in Science, aims to open up new career perspectives for highly qualified young researchers. The curriculum included personal reflection, training in entrepreneurial methods such as design thinking and a Q&A session with role models. Andrea Ernst, Head of Normal Flow Filtration Materials at Sartorius, participated as a mentor for intrapreneurship and shared her experiences: "In my journey from the lab to leading teams, I've found that innovation truly comes alive when research meets entrepreneurial spirit." Learn more about the event on the Sartorius blog: https://srtrs.info/phd-to-innovator-workshop
Working hard to bring personalized therapies to more people? Cell and gene therapies provide hope for patients in need of new medical solutions. These therapies have the potential to revolutionize treatments for genetic disorders, cancer, autoimmune diseases. To make these life-changing therapies accessible to more patients, our customers are pushing the boundaries of drug discovery, development, and manufacturing. And we are right at their side, committed to helping reveal the full potential of advanced therapies. We’re in this together. We enable faster and more affordable processes. Explore scalable solutions for more patients at www.sartorius.com/inthistogether
You’ll Never Research, Analyze, Develop, Optimize, or Work Alone Looking for a partner at every stage of your journey? With our innovative research tools, automated analytical instruments, bio-manufacturing and purification solutions, we aim to make drug discovery and production simpler, faster, and more sustainable. We don’t just understand the scientific aspects of our partners' research, development, and production. We listen, we act, we anticipate according to their very specific situations – from start to finish. We’re in this together. We offer leading solutions from drug discovery to production and final shipping. Discover our range of solutions at www.sartorius.com/inthistogether
In its first credit rating, Sartorius received a solid investment grade rating today. The international rating agency S&P Global Ratings assigned a long-term issuer rating of BBB with a stable outlook. Read Press Release: https://srtrs.info/investment-grade-rating
Great Minds Think Alike. Greater Minds Think Together. Working on your next breakthrough in life science and bioprocessing? People think scientific progress is about facts, figures, and results. What really drives progress, however, are people. But you can’t do it alone. You need a partner you can trust. At Sartorius, we see what fuels our partners’ research, development, and production: Their current and future challenges. Their opportunities. Their ups and downs. And they can be sure of one thing: We’re in this together. We are the partner to simplify progress - now and in the future. Let’s start working together at www.sartorius.com/inthistogether #SimplifyingProgress #LifeSciences #bioprocessing
Have you browsed our open positions lately? Sartorius offers diverse opportunities in Sales, Services, R&D, and in other teams. If you find one that matches your expertise, take the chance to elevate your career to the next level and become part of our team: www.sartorius.com/careers
From Stay-at-Home mom to Key Account Manager – meet Rowena! After graduating in biochemistry and kicking-off a sales career, Rowena decided to focus on her family. Ignoring the voices that predicted she would regress professionally, she stayed home with her children for 15 years. Today, she is thriving as a Key Account Manager at Sartorius, helping our customers to accelerate research and find treatments for various diseases. How did she manage? Read the full story: https://srtrs.info/opu02
